{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T03:39:21Z","timestamp":1778297961216,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.amepre.2013.03.019","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T02:01:22Z","timestamp":1373940082000},"page":"175-181","source":"Crossref","is-referenced-by-count":77,"title":["Challenges in Cervical Cancer Prevention"],"prefix":"10.1016","volume":"45","author":[{"given":"Rebecca B.","family":"Perkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherri","family":"Sheinfeld Gorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay A.","family":"Schulkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amepre.2013.03.019_bib1","article-title":"Human papillomavirus vaccination","year":"2010","journal-title":"Committee Opinion"},{"key":"10.1016\/j.amepre.2013.03.019_bib2","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Comitte on Immunization Practices","volume":"56","year":"2007","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.amepre.2013.03.019_bib3","article-title":"Cervical cytology screening","year":"2009","journal-title":"Practice Bulletin"},{"key":"10.1016\/j.amepre.2013.03.019_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"137","author":"Saslow","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.amepre.2013.03.019_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jpag.2008.09.002","article-title":"Obstetrician-gynecologists and the HPV vaccine: practice patterns, beliefs, and knowledge","volume":"22","author":"Leddy","year":"2009","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.amepre.2013.03.019_bib6","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1002\/cncr.27598","article-title":"Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009","volume":"118","author":"Hirth","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.amepre.2013.03.019_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/AOG.0b013e3182210034","article-title":"Low-risk human papillomavirus testing and other nonrecommended human papillomavirus testing practices among U.S. health care providers","volume":"118","author":"Lee","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.amepre.2013.03.019_bib8","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archinternmed.2010.134","article-title":"Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?","volume":"170","author":"Saraiya","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amepre.2013.03.019_bib9","unstructured":"Sheinfeld Gorin S, Westhoff C, NYPAC. The HPV vaccine: a promising intervetnion approach to increase dissemination. Oral presentation, Society of Behavioral Medicine Annual Meeting; Apr 10, 2010; Seattle WA."},{"key":"10.1016\/j.amepre.2013.03.019_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ypmed.2007.05.013","article-title":"Predictors of HPV vaccine acceptability: a theory-informed, systematic review","volume":"45","author":"Brewer","year":"2007","journal-title":"Prev Med"},{"key":"10.1016\/j.amepre.2013.03.019_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/10647440400020661","article-title":"Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists","volume":"12","author":"Raley","year":"2004","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.amepre.2013.03.019_bib12","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1158\/1055-9965.EPI-09-0184","article-title":"Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians","volume":"18","author":"Kahn","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.amepre.2013.03.019_bib13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s12325-011-0045-x","article-title":"The human papillomavirus (HPV) vaccine and cervical cancer: uptake and next steps","volume":"28","author":"Sheinfeld Gorin","year":"2011","journal-title":"Adv Ther"},{"key":"10.1016\/j.amepre.2013.03.019_bib14","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1016\/j.whi.2012.04.001","article-title":"What affects human papillomavirus vaccination rates? A qualitative analysis of providers' perceptions","volume":"22","author":"Perkins","year":"2012","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.amepre.2013.03.019_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/MLR.0b013e3181ca4015","article-title":"Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals","volume":"48","author":"Meissner","year":"2010","journal-title":"Med Care"},{"key":"10.1016\/j.amepre.2013.03.019_bib16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/jwh.2012.3562","article-title":"Recency of Pap testing and future testing plans among women aged 18-64: analysis of the 2007 Health Information National Trends Survey","volume":"21","author":"Ashok","year":"2012","journal-title":"J Womens Health (Larchmt)"},{"issue":"447","key":"10.1016\/j.amepre.2013.03.019_bib17","first-page":"e1","article-title":"Human papillomavirus and Papanicolaou tests screening interval recommendations in the U.S","volume":"205","author":"Roland","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amepre.2013.03.019_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.amepre.2009.05.019","article-title":"Obstetrician-gynecologists' practices and perceived knowledge regarding immunization","volume":"37","author":"Power","year":"2009","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.amepre.2013.03.019_bib19","unstructured":"Census. Overview of Race and Hispanic Origin: 2010. wwwcensusgov\/prod\/cen2010\/briefs\/c2010br-02pdf. 2010."},{"key":"10.1016\/j.amepre.2013.03.019_bib20","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","article-title":"Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study","volume":"377","author":"Brotherton","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.amepre.2013.03.019_bib21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/sextrans-2011-050234","article-title":"The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme","volume":"87","author":"Read","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.amepre.2013.03.019_bib22","first-page":"1","article-title":"Youth risk behavior surveillance\u2014U.S., 2011","volume":"61","author":"Eaton","year":"2012","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.amepre.2013.03.019_bib23","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.amepre.2013.03.019_bib24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.amepre.2013.03.019_bib25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/1059840511415861","article-title":"The uptake of human papillomavirus (HPV) vaccine among adolescent females in the U.S.: a review of the literature","volume":"27","author":"Bartlett","year":"2011","journal-title":"J Sch Nurs"},{"key":"10.1016\/j.amepre.2013.03.019_bib26","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1542\/peds.2011-0950","article-title":"Human papillomavirus vaccination series initiation and completion, 2008-2009","volume":"128","author":"Dorell","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.amepre.2013.03.019_bib27","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/j.vaccine.2011.01.052","article-title":"Human papillomavirus vaccine initiation among adolescent girls in high-risk communities","volume":"29","author":"Guerry","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2013.03.019_bib28","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.vaccine.2009.12.063","article-title":"Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation","volume":"29","author":"Rosenthal","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2013.03.019_bib29","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1089\/jwh.2004.13.791","article-title":"Beyond the Pap: assessing patients' priorities for the annual examination","volume":"13","author":"Becker","year":"2004","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.amepre.2013.03.019_bib30","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/AOG.0b013e3182329681","article-title":"Attitudes and practices of obstetrician-gynecologists regarding influenza vaccination in pregnancy","volume":"118","author":"Kissin","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.amepre.2013.03.019_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/gyno.2000.5901","article-title":"Cervical cancer outcomes analysis: impact of age, race, and comorbid illness on hospitalizations for invasive carcinoma of the cervix","volume":"79","author":"Brooks","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.amepre.2013.03.019_bib32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.currproblcancer.2007.01.001","article-title":"Factors underlying disparities in cervical cancer incidence, screening, and treatment in the U.S","volume":"31","author":"Akers","year":"2007","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.amepre.2013.03.019_bib33","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/01.mlr.0000160418.72625.1c","article-title":"Physician and patient gender concordance and the delivery of comprehensive clinical preventive services","volume":"43","author":"Flocke","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.amepre.2013.03.019_bib34","doi-asserted-by":"crossref","first-page":"288","DOI":"10.7326\/0003-4819-138-4-200302180-00007","article-title":"The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care","volume":"138","author":"Fisher","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amepre.2013.03.019_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-138-4-200302180-00006","article-title":"The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care","volume":"138","author":"Fisher","year":"2003","journal-title":"Ann Intern Med"},{"issue":"526","key":"10.1016\/j.amepre.2013.03.019_bib36","first-page":"e1","article-title":"Variation in the rates of operative delivery in the U.S","volume":"196","author":"Clark","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amepre.2013.03.019_bib37","unstructured":"The Dartmouth Atlas of Healthcare. 2012. http:\/\/www.dartmouthatlas.org\/keyissues\/issue.aspx?con=2939."},{"issue":"2","key":"10.1016\/j.amepre.2013.03.019_bib38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.amepre.2012.09.061","article-title":"Geographic variability in human papillomavirus vaccination among U.S. young women","volume":"44","author":"Wei","year":"2013","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.amepre.2013.03.019_bib39","unstructured":"Gordon N. How does the adult Kaiser Permanente membership in Northern California compare with the Larger Community? www.dor.kaiser.org\/external\/uploadedFiles\/content\/research\/mhs\/_2011_Revised_Site\/Documents_Special_Reports\/comparison_kaiser_vs_nonKaiser_adults_kpnc(1).pdf. 2006."},{"key":"10.1016\/j.amepre.2013.03.019_bib40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJM199508313330907","article-title":"Regional variation across the U.S. in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries","volume":"333","author":"Pilote","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amepre.2013.03.019_bib41","unstructured":"SEER. SEER stat fact sheets: cervix uteri. Incidence & mortality seer.cancer.gov\/statfacts\/html\/cervix.html - incidence-mortality."},{"key":"10.1016\/j.amepre.2013.03.019_bib42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3322\/canjclin.52.3.134","article-title":"Health literacy and cancer communication","volume":"52","author":"Davis","year":"2002","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.amepre.2013.03.019_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.amepre.2012.04.009","article-title":"Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services","volume":"43","author":"Sabatino","year":"2012","journal-title":"Am J Prev Med"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379713002924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379713002924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T14:58:29Z","timestamp":1539529109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379713002924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0749379713002924"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2013.03.019","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}